Cleveland BioLabs
CBLI
#10312
Rank
NZ$83.25 M
Marketcap
NZ$5.38
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -NZ$3.97 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are NZ$0.63 Million. In 2020 the company made an earning of -NZ$4.36 Million a decrease over its 2019 earnings that were of -NZ$4.01 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$3.97 Million-9.07%
2020-NZ$4.36 Million8.8%
2019-NZ$4.01 Million-50.81%
2018-NZ$8.15 Million-14.3%
2017-NZ$9.51 Million-11.88%
2016-NZ$10.79 Million-50.9%
2015-NZ$21.97 Million-10.24%
2014-NZ$24.47 Million-37.5%
2013-NZ$39.16 Million-23.2%
2012-NZ$50.99 Million19.68%
2011-NZ$42.6 Million133.81%
2010-NZ$18.22 Million68.22%
2009-NZ$10.83 Million-55.51%
2008-NZ$24.34 Million-45.62%
2007-NZ$44.77 Million255.63%
2006-NZ$12.59 Million198.18%
2005-NZ$4.23 Million-1.25%
2004-NZ$4.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$26.78 B-573,529.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$52.80 B-1,130,865.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.41 B-330,229.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.99 B-278,331.17%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$16.28 B-348,757.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$16.98 B-363,812.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$19.86 Million 325.20%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.39 Billion 8,217.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.81 Million 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA